SSRIs and movement disorders: Is serotonin the culprit?

Human Psychopharmacology

Volumn 11, Issue SUPPL. 2, 1996, Pages

  Leonard, B E ^a   Faherty, C ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

5 Hydroxytryptamine; 5HT receptors; 5HT dopamine interactions; Dystonia; Parkinson's disease; Sigma receptors; Torticollis

Indexed keywords

1,3 BIS(2 METHYLPHENYL)GUANIDINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; AMPHETAMINE; CITALOPRAM; CLOZAPINE; CYPROHEPTADINE; DOPAMINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; LIGAND; MIANSERIN; NEUROLEPTIC AGENT; PAROXETINE; PENTAZOCINE; PRECLAMOL; RACLOPRIDE; REMOXIPRIDE; RISPERIDONE; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SIGMA OPIATE RECEPTOR;

AKATHISIA; CLINICAL TRIAL; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MOTOR DYSFUNCTION; NEUROMODULATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RECEPTOR AFFINITY; RED NUCLEUS; REVIEW; SEROTONINERGIC SYSTEM; TORTICOLLIS;

EID: 0029814626     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199606)11:2+3.0.CO;2-B     Document Type: Review

References (47)

1. Arya, D. K. and Szabadi, E. (1993). Dyskinesias associated with fluvoxamine. Journal of Clinical Psychopharmacology, 13, 365-366.
2. Azmita, E. C. (1978). The serotonergic producing neurons in the midbrain median and dorsal raphe nuclei. In: Handbook of Psychopharmacology. Chemical Pathways in the Brain, Vol. 9, Ivesen, L. L., Iversen, S. D. and Snyder, S. H. (Eds), pp. 233-314. Raven Press, New York.
3. Baldessarini, R. J. and Marsh, E. (1990). Fluoxetine and side effects. Archives of General Psychiatry, 47, 191-192.
4. Baldwin, D., Fineberg, N. and Montgomery, S. (1991). Fluoxetine, fluvoxamine and extra pyramidal tract disorders. International Clinical Psychopharmacology, 6, 51-58.
5. Bouchard, R. H., Pourcher, E. and Vincent, P. (1989). Fluoxetine and extrapyramidal side effects. American Journal of Psychiatry, 146, 1352-1353.
6. Brod, T. M. (1989). Fluoxetine and extrapyramidal side effects. American Journal of Psychiatry, 146, 1352-1353.
7. Carlsson, A. and Lindqvist, M. (1963). Effect of chlorpromazine and haloperidol on formation of 3-methoxytryptamine and normetanephrine in mouse brain. Acta Pharmcologia et Toxicologa, 20, 140-144.
8. Chase, T. N., Ng, L. H. Y. and Watanabe, A. M. (1972). Parkinson's disease - modification by 5-hydroxytryptophan. Neurology, 22, 479-484.
9. Chouinard, D. and Sultan, S. (1992). A case of Parkinson's disease exacerbrated by fluoxetine. Human Psychopharmacology, 7, 63-66.
10. Committee on Safety of Medicines (1993). Dystonia and withdrawal symptoms with paroxetine. Current Problems in Pharmacovigilance, 19, 1.
11. Davies, J. and Tongrach, P. (1978). Neuropharmacological studies on the nigro-striatal and raphe striatal system in the rat. European Journal of Pharmacology, 51, 91-100.
12. Faherty, C., Earley, B. and Leonard, B. E. (1996). Biochemical and behavioural effects of SSRIs following direct micro injection into the left red nucleus of the rat. Journal of Psychopharmacology, in press.
13. Dray, A., Gongye, T. J. and Oakley, N. R. (1976). Evidence of the existence of a raphe projection to the substantia nigra of the rat. Brain Research, 113, 45-57.
14. Glennon, R. A. and Dukat, M. (1995). Serotonin receptor sub-types. In: Psychopharmacology: The Fourth Generation of Progress, Bloom, F. E. and Kupfer, D. J. (Eds), Raven Press, New York, pp. 415-429.
15. Green, A. R. and Backus, L. I. (1990). Animal models of serotonin behaviour. Annals of the New York Academy of Sciences, 600, 237-249.
16. Grundlack, A. L., Largent, B. L. and Snyder, S. H. (1986). Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1-propyl)-piperadine. Journal of Neuroscience, 6, 1757-1770.
17. Hamilton, M. S. and Opler, L. A. (1992). Akathisia, suicidality and fluoxetine. Journal of Clinical Psychiatry, 53, 401-406.
18. Herve, D., Pickel, V. M. and Joh, T. H. (1987). Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons. Brain Research, 435, 71-83.
19. Itzhak, Y. (1994). Multiple sigma binding sites in the brain. In: Sigma Receptors, Itzhak, Y. (Ed.), Academic Press, New York, pp. 113-138.
20. Iyengar, S., Dilworth, V., Mick, S. J. and Contrecras, P. C. (1990). Sigma receptors modulate both A9 and AlO dopaminergic neurons in the rat brain: functional interactions with NMDA receptors. Brain Research, 524, 322-326.
21. Jacobs, M. B. (1983). Diltiazem and akathisa. Annals of Internal Medicine, 99, 794-795.
22. Jacobs, B. L. and Fornal, C. A. (1991). Activity of brain serotonergic neurones in animal behavior. Pharmacological Reviews, 43, 563-578.
23. Jacobs, B. L. and Fornal, C. A. (1993). 5-HT and motor control: a hypothesis. Trends in Neuroscience, 16, 346-352.
24. Jones, D. L., Morgenson, G. J. and Wu, M. (1981). Injections of dopaminergic, cholinergic, serotonergic and GABAergic drugs into the nucleus aceumbens: effect on locomotor activity. Neuropharmacology, 20, 29-37.
25. Junien, J. L. and Leonard, B. E. (1989). Drugs acting on sigma and phencyclidine receptors: a review of their nature, function and possible therapeutic importance. Clinical Neuropharmacology, 12, 353-374.
26. Korsgaard, S., Gerlach, J. and Christensson, E. (1985). Behavioural aspects of serotonin-dopamine interactions in the monkey. European Journal of Pharmacology, 118, 245-252.
27. Leonard, B. E. (1994). Serotonin receptors - where are they going? International Clinical Pharmacology, 9, 7-17.
28. Liebman, J. and Neale, R. (1980). Neuroleptic induced acute dyskinesias in squirrel monkeys: correlation with propensity to cause extrapyramidal side effects. Psychopharmacology, 68, 25-29.
29. Lipinski, J. F., Mallya, G. and Zimerman, R. N. (1989). Fluoxetine induced akathsia: clinical and theoretical implications. Journal of Clinical Psychiatry, 50, 339-342.
30. Loscher, W., Annies, R. and Richter, A. (1994). Marked regional disturbance in brain metabolism of monoamineric neurotransmitters in the genetically dystonic hamster. Brain Research, 658, 199-208.
31. Ludwig, C. L., Weinberger, D. R. and Bruno, G. (1986). Buspirone, Parkinson's disease and locus coeruleus. Clinical Neuropharmacology, 9, 373-378.
32. Martin, W. J., de Costa, B. R. and Walker, J. M. (1991). Iontophoretic effects of putative sigma ligands on rat cerebellar purkinje cells. Society of Neuroscience Abstracts, 17, 593.
33. Matsumoto, R. R. and Walker, J. M. (1992). Iontophoretic effects of putative sigma ligands on rubral neurons in the rat. Brain Research Bulletin, 29, 419-425.
34. Meltzer, H. Y., Young, M., Metz, J., Fang, V. S., Schyue, P. M. and Arora, R. C. (1979). Extrapyrimidal side-effects and increased serum prolactin following fluoxetine, a new antidepressant. Journal of Neural Transmission, 45, 165-175.
35. Nicolaou, N., Garcia-Munoz, M. and Arbothnoff, G. (1979). Interaction between serotonergic and dopaminergic systems in rats demonstrated by small unilateral lesions of the raphe nucleus. European Journal of Pharmacology, 57, 295-305.
36. Patrick, S. L., Walker, J. M., Perkel, J. M., Lockwood, M. and Patrick. R. O. (1993). Increases in rat strital extracellular dopamine and vacuous chewing produced by two sigma ligands. European Journal of Pharmacology, 231, 243-249.
37. Porsolt, R. D. and Jalfre, M. (1981). Neuroleptic-induced acute dyskinesias in rhesus monkeys. Psychopharmacology, 75, 16-21.
38. Steinbusch, H. W. M. (1981). Distribution of serotonin immunoreactivity in the central nervous system of the rat-cell bodies and terminals. Neuroscience, 4, 557-618.
39. Steinfels, G. F., Tam, W. T. and Cook, L. (1989). Electrophysiological effects of selective sigma receptor agonists, antagonists and the selective phencyclidine receptor agonist MK801, on mid brain dopamine neurons. Neuropharmacology, 2, 201-208.
40. Sternbach, H. (1991). The serotonin syndrome. American Journal of Psychiatry, 148, 705-713.
41. Stewart, B. R., Jenner, P. and Marsden, C. D. (1989). Induction of purporelan chewing behaviour in rats by 5HT agonist drugs. European Journal of Pharmacology, 162, 101-107.
42. Tate, J. L. (1989). Extrapyramidal symptoms in a patients taking haloperidol and fluoxetine. American Journal of Psychiatry, 146, 399-400.
43. Tanis, H., Okayama, A., Yamatodani, A., Hayashi, M. and Hashimoton, I. K. (1991). Alterations in the metabolism of serotonin and dopamine in the mouse brain following a single administration of allyl nitrite, which induces long-term dyskinesia. Toxicology Letters, 58, 323-328.
44. Wadenberg, M. L., Cortizo, L. and Ahlenius, S. (1994). Evidence for specific interactions between 5HT1A and dopamine D2 receptor mechanisms in the mediation of extrapyramidal motor functions in the rat. Pharmacology, Biochemistry and Behaviour, 47, 509-513.
45. Walker, J. M., Bowen, W. D., Patrick, S. L., Williams, W. E. and Marsearella, S. W. (1993). A comparison of (-) deoxybenzomorphans devoid of opiate activity with their dextro rotatory phenolic counterparts suggests a role for sigma type receptors for psychotomimetic opiates and antipsychotic drugs. Proceedings of the National Academy of Sciences USA, 83, 8784-8788.
46. Walker, J. M., Martin, W. J., Hohmann, A. G., Heinstreat, M. K. and Roth, J. S. (1994). Role of sigma receptors in brain mechanism of movement. In: Sigma Receptors, Itzhak, Y. (Ed.), Academic Press, New York, pp. 205-254.
47. Yamamoto, B. and Freed, C. R. (1984). Asymmetric dopamine and serotonin in nigro striatal and limbic structures of trained circling rats. Brain Research, 297, 115-119.